(Q36761189)

16 August 2017

1 reference

title

Current insights into the biology and pathogenesis of Pneumocystis pneumonia (English)

1 reference

16 August 2017

0 references

Charles F Thomas

1

1 reference

16 August 2017

Andrew H Limper

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

Nature Reviews Microbiology

16 August 2017

published in

1 reference

16 August 2017

volume

5

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

298-308

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro1621

16 August 2017

exact match

0 references

cites work

Pneumocystis pneumonia

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis nomenclature.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii nomenclature: response to Cushion and Stringer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii: has the name really been changed?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii versus Pneumocystis jirovecii (jiroveci) Frenkel.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Presence of Pneumocystis carinii DNA in pond water

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Geographic distribution of human immunodeficiency virus-associated Pneumocystis carinii pneumonia in San Francisco

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Update on the epidemiology and transmission of Pneumocystis carinii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Current epidemiology of Pneumocystis pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Clinical correlation of variations in the internal transcribed spacer regions of rRNA genes in Pneumocystis carinii f.sp. hominis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Transmission of Pneumocystis carinii from patients to hospital staff

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Natural mode of acquisition for de novo infection with Pneumocystis carinii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Association of Chronic Obstructive Pulmonary Disease Severity andPneumocystisColonization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pulmonary complications of HIV infection: autopsy findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Quantitation of absolute Pneumocystis carinii nuclear DNA content. Trophic and cystic forms isolated from infected rat lungs are haploid organisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Sporogony inPneumocystis carinii: Synaptonemal Complexes and Meiotic Nuclear Divisions Observed in Precysts1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

An Official ATS Workshop Summary: Recent advances and future directions in pneumocystis pneumonia (PCP).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

The challenge of Pneumocystis carinii culture.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Gene arrays at Pneumocystis carinii telomeres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

The genome of Pneumocystis carinii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Development of murine monoclonal antibodies to Pneumocystis carinii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Purification and initial characterization of a ferret Pneumocystis carinii surface antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Carbohydrate recognition domain of surfactant protein D mediates interactions with Pneumocystis carinii glycoprotein A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Genetics of surface antigen expression in Pneumocystis carinii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Host Species-Specific Antigenic Variation of a Mannosylated Surface Glycoprotein of Pneumocystis carinii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Monoclonal antibodies to Pneumocystis carinii: identification of specific antigens and characterization of antigenic differences between rat and human isolates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Type-II major-surface-glycoprotein family of Pneumocystis carinii under the control of novel expression elements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

A single-copy gene encodes Kex1, a serine endoprotease of Pneumocystis jiroveci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

A Pneumocystis carinii multi-gene family with homology to subtilisin-like serine proteases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Cell surface protease PRT1 identified in the fungal pathogen Pneumocystis carinii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Fungal ß(1,3)-D-glucan synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Cell wall assembly by Pneumocystis carinii. Evidence for a unique gsc-1 subunit mediating beta -1,3-glucan deposition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii contains a functional cell-division-cycle Cdc2 homologue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Differential regulation of growth and checkpoint control mediated by a Cdc25 mitotic phosphatase from Pneumocystis carinii.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Signal propagation and regulation in the mating pheromone response pathway of the yeast Saccharomyces cerevisiae

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Complementation and characterization of the Pneumocystis carinii MAPK, PCM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii STE11, an HMG-box protein, is phosphorylated by the mitogen activated protein kinase PCM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Expression analysis of PCSTE3, a putative pheromone receptor from the lung pathogenic fungus Pneumocystis carinii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Lung Epithelial Cells and Extracellular Matrix Components Induce Expression of Pneumocystis carinii STE20 , a Gene Complementing the Mating and Pseudohyphal Growth Defects of ste20 Mutant Yeast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Mitogen-activated protein kinase Mkp1 of Pneumocystis carinii complements the slt2Delta defect in the cell integrity pathway of Saccharomyces cerevisiae

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Mkp1 of Pneumocystis carinii associates with the yeast transcription factor Rlm1 via a mechanism independent of the activation state

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Biochemical requirements for PCBCK1 kinase activity, the Pneumocystis carinii MEKK involved in cell wall integrity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii BCK1 functions in a mitogen-activated protein kinase cascade regulating fungal cell-wall assembly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Characterization of Pneumocystis carinii PHR1, a pH-regulated gene important for cell wall Integrity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii cell wall biosynthesis kinase gene CBK1 is an environmentally responsive gene that complements cell wall defects of cbk-deficient yeast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with pneumocystis pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii Cell Wall β-Glucans Initiate Macrophage Inflammatory Responses through NF-κB Activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Macrophage internalization of fungal beta-glucans is not necessary for initiation of related inflammatory responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Immune recognition. A new receptor for beta-glucans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Toll-like receptor 2 mediates alveolar macrophage response to Pneumocystis murina

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Vitronectin and fibronectin function as glucan binding proteins augmenting macrophage responses to Pneumocystis carinii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

TNF receptor signaling contributes to chemokine secretion, inflammation, and respiratory deficits during Pneumocystis pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

CXCR3 and IFN protein-10 in Pneumocystis pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii infection in transgenic B cell-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Role of type I IFNs in pulmonary complications of Pneumocystis murina infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Inflammatory Responses to Pneumocystis carinii in Mice Selectively Depleted of Helper T Lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis pneumonia increases the susceptibility of mice to sublethal hyperoxia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii pneumonia in patients without AIDS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Alveolar damage in AIDS-related Pneumocystis carinii pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii inhibits cyclin-dependent kinase activity in lung epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Quantitative structure-activity relationship studies of a series of sulfa drugs as inhibitors of Pneumocystis carinii dihydropteroate synthetase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

The crystal structure of thymidylate synthase from Pneumocystis carinii reveals a fungal insert important for drug design

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Inability of Pneumocystis organisms to incorporate bromodeoxyuridine suggests the absence of a salvage pathway for thymidine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

The Pneumocystis carinii drug target S-adenosyl-L-methionine:sterol C-24 methyl transferase has a unique substrate preference.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii Pneumonia Among Patients Without AIDS at a Cancer Hospital

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Molecular basis for atovaquone resistance in Pneumocystis jirovecii modeled in the cytochrome bc(1) complex of Saccharomyces cerevisiae

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: Epidemiological Implications.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Prophylaxis Failure Is Associated with a SpecificPneumocystis cariniiGenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

Pneumocystis carinii is not universally transmissible between mammalian species

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

7 January 2021

Analysis of Pneumocystis carinii introns

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

7 January 2021

Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

7 January 2021

Signal transduction in Pneumocystis carinii: characterization of the genes (pcg1) encoding the alpha subunit of the G protein (PCG1) of Pneumocystis carinii carinii and Pneumocystis carinii ratti.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

7 January 2021

Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1621

7 January 2021

Identifiers

DOI

10.1038/NRMICRO1621

1 reference

16 August 2017

1 reference